# positions[].organizations[].parent[].label
Texas A&M University Naresh K. Vashisht College of Medicine

# positions[].organizations[].label
Texas A&M University Naresh K. Vashisht College of Medicine

# keywords[]
Serotonin Plasma Membrane Transport Proteins

# keywords[]
Va Augmentation And Swritching Treatments For Depression (vast-d) Study

# keywords[]
Clinical Trials And Supportive Activities

# keywords[]
6 Evaluation Of Treatments And Therapeutic Interventions

# keywords[]
Serotonin Plasma Membrane Transport Proteins

# keywords[]
United States Department Of Veterans Affairs

# keywords[]
3214 Pharmacology And Pharmaceutical Sciences

# keywords[]
Clinical Trials And Supportive Activities

# keywords[]
6 Evaluation Of Treatments And Therapeutic Interventions

# educationAndTraining[].organization.label
Stanford Medicine - (Stanford, California, United States)

# educationAndTraining[].organization.label
Baylor College of Medicine - (Houston, Texas, United States)

# educationAndTraining[].organization.label
Baylor College of Medicine - (Houston, Texas, United States)

# educationAndTraining[].organization.label
Baylor College of Medicine - (Houston, Texas, United States)

# publications[].label
Characteristics of U.S. Veteran Patients with Major Depressive Disorder who require "next-step" treatments: A VAST-D report.

# publications[].label
Plasma choline and blood cholinesterases in aged rats.

# publications[].label
The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

# publications[].label
INCREASED BEHAVIORAL-EFFECTS OF DOPAMINE AGONISTS IN AGED RODENTS

# publications[].label
A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics.

# publications[].label
A novel computer-controlled conditioned avoidance apparatus for rats.

# publications[].label
Incidence of startle prepulse inhibition deficits in schizophrenics

# publications[].label
5HTTLPR polymorphism and enlargement of the pulvinar: unlocking the backdoor to the limbic system.

# publications[].label
5-HT2A antagonism does not affect catalepsy in rats

# publications[].label
Anterior thalamic volume in schizophrenia and mood disorders

# publications[].label
Predictability of Nonremitting Depression After First 2Weeks of Antidepressant Treatment: A VAST-D Trial Report.

# publications[].label
General Predictors and Moderators of Depression Remission: A VAST-D Report.

# publications[].label
Behavioral and frontal cortical metabolic effects of apomorphine and muscimol microinjections into the mediodorsal thalamic nucleus.

# publications[].label
Subthalamic nucleus microinjections of 5-HT2 receptor antagonists suppress stereotypy in rats.

# publications[].label
VA/VL THALAMIC CELL NUMBER IN SCHIZOPHRENIA AND MOOD DISORDERS

# publications[].label
Behavioral evidence for supersensitivity after chronic bromocriptine administration.

# publications[].label
Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia.

# publications[].label
Childhood adversity and adulthood major depressive disorder.

# publications[].label
Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.

# publications[].label
Age-related alterations in the rodent brain cholinergic system and behavior.

# publications[].label
Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.

# publications[].label
The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations.

# publications[].label
M100,907 acts at both the nucleus accumbens and the prefrontal cortex to mediate the enhancement of the suppression of conditioned avoidance response by haloperidol

# publications[].label
Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions.

# publications[].label
Increased number of neurons in the limbic thalamus in major depressive disorder

# publications[].label
Subchronic buspirone, mesulergine, and ICS 205-930 lack effects on D1 and D2 dopamine binding in the rat striatum during chronic haloperidol treatment.

# publications[].label
The role of the MAP kinase ERK pathway in the antipsychotic actions of clozapine

# publications[].label
Effects of serotonergic agents on apomorphine-induced locomotor activity.

# publications[].label
Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504.

# publications[].label
Further evidence for a 5-HT-1C modulation of apomorphine-induced locomotor activity

# publications[].label
Is the mechanism of action of antipsychotic agents mediated through the MAP kinase signal transduction system?

# publications[].label
Major depression, 5HTTLPR genotype, suicide and antidepressant influences on thalamic volume.

# publications[].label
Elevated neuron number in the limbic thalamus in major depression.

# publications[].label
Decreased response latency time of aged C57BL/6J male mice to benzodiazepines

# publications[].label
Effect of next-step antidepressant treatment on suicidal ideation: findings from the VAST-D trial.

# publications[].label
Further evidence for a role of the 5-HT2A receptor in the mediation of antipsychotic activity

# publications[].label
Aging alters amphetamine-induced stereotyped gnawing and neostriatal elimination of amphetamine in mice.

# publications[].label
Factors Affecting Antidepressant Response Trajectories: A Veterans Affairs Augmentation and Switching Treatments for Improving Depression Outcomes Trial Report

# publications[].label
Stereological estimate of total thalamic neuron number in schizophrenics

# publications[].label
Normal oligodendrocyte cell numbers in anterior thalamus in schizophrenia Normal oligodendrocyte cell numbers in anterior thalamus in schizophrenia

# publications[].label
The effect of serotonergic agents on haloperidol-induced catalepsy.

# publications[].label
Differences in treatment effect among clinical subgroups in a randomized clinical trial of long-acting injectable risperidone and oral antipsychotics in unstable chronic schizophrenia.

# publications[].label
N100 evoked potential latency variation and startle in schizophrenia.

# publications[].label
Cognitive improvement in schizophrenia and schizoaffective disorder by augmentation of risperidone with galantamine

# publications[].label
Association of NOTCH4 with schizophrenia in VA Coop Study # 366

# publications[].label
Regional uptake of [35S]-cysteine in rat brain after arterial injection.

# publications[].label
Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat.

# publications[].label
Antiretrovirals and Psychotropics: Drug Interactions and Complications

# publications[].label
Continuation phase treatment outcomes for switching, combining, or augmenting strategies for treatment-resistant major depressive disorder: A VAST-D report.

# publications[].label
Use of obesity-related care by psychiatric patients.

# publications[].label
Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial.

# publications[].label
The MEK/ERK map kinase pathway in antipsychotic actions

# publications[].label
Changes in evoked potential latency variation over time are associated with changes in EP and startle gating in schizophrenic patients

# publications[].label
Age-related changes in rat brain capillaries.

# publications[].label
GFAP and Rab3a immunoreactivity in the thalamus of schizophrenics

# publications[].label
Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.

# publications[].label
Galantamine improves cognition in schizophrenic patients stabilized on risperidone.

# publications[].label
A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial. ARCS Study Group. Assessment of Risperdal in a Clinical Setting.

# researcherOn[].awardedBy.label
Central Texas Veterans Health Care System - (Waco, Texas, United States)

# researcherOn[].awardedBy.preferredLabel
Central Texas Veterans Health Care System

# streetAddress
Texas A&M Health Science Center; Instructional Admin; 1114 TAMUS

# organizations[]
Texas A&M University Naresh K. Vashisht College of Medicine

# schools[]
Texas A&M University Naresh K. Vashisht College of Medicine